Dxpime TZ 250mg/31.25mg Injection
Marketer
Doux Healthcare Pvt Ltd
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Dxpime TZ 250mg/31.25mg Injection
Tazicef Injection, containing 250mg/31.25mg of a dual antibiotic formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and skin rashes; localized injection site reactions (redness, swelling, pain) may also occur, typically resolving spontaneously. Worsening side effects necessitate immediate medical consultation. Seek urgent medical attention for allergic responses (skin reactions, itching, swelling, respiratory distress). Prior to commencing treatment, disclose all current medications and pre-existing health conditions to your physician. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs.
Primary Ingredients of Dxpime TZ 250mg/31.25mg Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Dxpime TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Dxpime TZ 250mg/31.25mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Dxpime TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Dxpime TZ 250mg/31.25mg Injection:
Administering this medication requires a healthcare professional; please follow their instructions.
How Dxpime TZ 250mg/31.25mg Injection works:
Dxpime TZ Injection, containing 250mg Cefepime and 31.25mg Tazobactum, combines an antibiotic with a beta-lactamase inhibitor. Cefepime's antibacterial action disrupts bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime, thus broadening Cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Dxpime TZ 250mg/31.25mg Injection alongside alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Dxpime TZ 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Dxpime TZ, 250mg/31.25mg, presents minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no discernible harm to the infant.
DrivingUNSAFE
Following administration of Dxpime TZ 250mg/31.25mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Caution is advised when administering Dxpime TZ 250mg/31.25mg Injection to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Dxpime TZ 250mg/31.25mg Injection in patients with liver impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary for this patient population. Physician consultation is recommended.
What if you forget to take Dxpime TZ 250mg/31.25mg Injection :
Omit a scheduled Dxpime TZ 250mg/31.25mg Injection? Seek your physician's advice.
Facts to Know About Dxpime TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently